Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network.
- Published In:
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 65(9), 1416-1422 (2024)
- Authors:
- Fosse, Aurelien, Hadoux, Julien, Girot, Paul, Beron, Amandine, Afchain, Pauline, Cottereau, Anne-Segolene, Baudin, Eric, Dierickx, Lawrence O, Lecomte, Thierry, Perrier, Marine, Lepage, Come, Bouhier-Leporrier, Karine, Goichot, Bernard, Lachachi, Boumediene, Walter, Thomas, Durand, Alice
- Database ID:
- RPEP-08208
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08208APA
Fosse, Aurelien; Hadoux, Julien; Girot, Paul; Beron, Amandine; Afchain, Pauline; Cottereau, Anne-Segolene; Baudin, Eric; Dierickx, Lawrence O; Lecomte, Thierry; Perrier, Marine; Lepage, Come; Bouhier-Leporrier, Karine; Goichot, Bernard; Lachachi, Boumediene; Walter, Thomas; Durand, Alice. (2024). Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 65(9), 1416-1422. https://doi.org/10.2967/jnumed.123.267363
MLA
Fosse, Aurelien, et al. "Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network.." Journal of nuclear medicine : official publication, 2024. https://doi.org/10.2967/jnumed.123.267363
RethinkPeptides
RethinkPeptides Research Database. "Peptide Receptor Radionuclide Therapy or Everolimus in Metas..." RPEP-08208. Retrieved from https://rethinkpeptides.com/research/fosse-2024-peptide-receptor-radionuclide-therapy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.